H.C. Wainwright Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $30

Futu NewsJan 13 20:31 · Ratings

Tyra Biosciences Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow JonesJan 13 20:13 · Ratings

FDA Grants IND Clearance For Tyra Biosciences' TYRA-300

RTTNewsJan 11 02:15

Tyra Biosciences' TYRA-300 Gets US FDA Clearance for Phase 2 Trial in Non-Muscle Invasive Bladder Cancer

MT NewswiresJan 10 23:49

Express News | Tyra Biosciences Receives Ind Clearance From FDA to Proceed With Phase 2 Study of Tyra-300 in Non-Muscle Invasive Bladder Cancer (Surf302)

BreakingsJan 10 21:00

UBS Initiates TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Announces Target Price $28

Futu NewsJan 7 19:37 · Ratings